As one of the major causes of acute ischemic stroke, intracranial arterial stenosis necessitates an intervention that ranges from medical treatment to balloon angioplasty and stenting. Self-expandable stents (SES) and balloon-mounted stents (BMS) are two types of stents and their comparative efficacy and safety for intracranial stenosis are not well established.
Methods
Studies that investigate balloon-mounted stenting for intracranial stenosis were extracted from PubMed, Scopus, and Cochrane library. We sought to gather data on the success rate, change in mean arterial stenosis, and complications such as minor and major stroke and death (MMD), symptomatic intracranial hemorrhage, myocardial infarction, all-cause mortality, and in-stent re-stenosis.
Results
3049 patients from 35 studies were included in this study. 20 studies investigated BMS alone and others compared BMS with SES. BMS was significantly more effective in reducing the degree of stenosis compared to SES (Difference in mean −5.953, CI 95% −7.727 to −4.179), had less complications compared to SES such as MMD (8.5% vs. 11.2%) and less in-stent re-stenosis (18.6% vs. 19.6%), but patients with SES experienced a lower rate of all-cause mortality(1.7% vs. 4.1%).
Conclusion
Intracranial stenting with BMS is more effective in reducing the degree of stenosis and has lower rates of complications when compared to SES.
AbdelRazekMAMowlaAHojnackiD, et al.Prior asymptomatic parenchymal hemorrhage does not increase the risk for intracranial hemorrhage after intravenous thrombolysis. Cerebrovascular Diseases (Basel, Switzerland)2015; 40: 201–204.
2.
SinghKMowlaAMehlaS, et al.Safety of intravenous thrombolysis for acute ischemic stroke in patients with preexisting intracranial neoplasms: a case series. International Journal of Stroke : Official Journal of the International Stroke Society2015; 10: E29–E30.
3.
HolmstedtCATuranTNChimowitzMI. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. The Lancet Neurology2013; 12: 1106–1114.
4.
ParkSKimJHKwakJK, et al.Intracranial stenting for severe symptomatic stenosis: self-expandable versus balloon-expandable stents. Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences2013; 19: 276–282.
5.
LeeHKKwakHSChungGH,et al.Balloon-expandable stent placement in patients with immediate reocclusion after initial successful thrombolysis of acute middle cerebral arterial obstruction. Interv Neuroradiol2012; 18: 80–88.
6.
QureshiAIAl-SenaniFMHusainS, et al.Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations*. J Neuroimaging2012; 22: 1–13.
7.
DerdeynCPChimowitzMILynnMJ, et al.Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. The Lancet2014; 383: 333–341.
8.
AlexanderMJZaunerAChaloupkaJC, et al.WEAVE Trial: final results in 152 on-label patients. Stroke2019; 50: 889–894.
9.
EggebrechtHHaudeMVon BirgelenC, et al.Nonsurgical retrieval of embolized coronary stents. Catheter Cardiovasc Interv2000; 51: 432–440.
10.
MiaoZSongLLiebeskindDS, et al.Outcomes of tailored angioplasty and/or stenting for symptomatic intracranial atherosclerosis: a prospective cohort study after SAMMPRIS. J Neurointerv Surg2015; 7: 331–335.
11.
HtayTLiuMW. Drug-eluting stent: a review and update. Vasc Health Risk Manag2005; 1: 263–276.
12.
AlurkarAKaranamLSPOakS,et al.Role of balloon-expandable stents in intracranial atherosclerotic disease in a series of 182 patients. Stroke2013; 44: 2000–2003.
13.
HassanAEMohammadenMHRabahRR,et al.Initial experience with the next-generation resolute onyx zotarolimus-eluting stent in symptomatic intracranial atherosclerotic disease. Front Neurol2020; 11.
14.
RohdeSSeckingerJHähnelS,et al.Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients. Int J Stroke2013; 8: 87–94.
15.
MaciejewskiDTekieliLKabłak-ZiembickaA, et al.Transradial approach for vertebral artery stenting. Postepy w Kardiologii Interwencyjnej2015; 11: 32–36.
16.
MohammadenMHNogueiraRGTekleW, et al.Safety and efficacy of balloon-mounted stent in the treatment of symptomatic intracranial atherosclerotic disease: a multicenter experience. J Neurointerv Surg2021.
17.
AlsidawiSEffatMRahmanS,et al.The role of vascular imaging in guiding routine percutaneous coronary interventions: a meta-analysis of bare metal stent and drug-eluting stent trials. Cardiovasc Ther2015; 33: 360–366.
18.
MoriTFukuokaMKazitaK,et al.Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol1998; 19: 1525–1533.
19.
WangZWangCLiC,et al.Stenting for symptomatic intracranial vertebrobasilar artery stenosis in northeast of China: a single-center study. Front Neurol2020; 11: 609286.
20.
LiuLZhaoXMoD,et al.Stenting for symptomatic intracranial vertebrobasilar artery stenosis: 30-day results in a high-volume stroke center. Clin Neurol Neurosurg2016; 143: 132–138.
21.
KansaraAPandeyPTiwariA,et al.Stenting of acute and subacute intracranial vertebrobasilar arterial occlusive lesions. J Neurointerv Surg2012; 4: 274–280.
22.
DornFProthmannSWunderlichS,et al.Stent angioplasty of intracranial stenosis: single center experience of 54 cases. Clin Neuroradiol2012; 22: 149–156.
23.
MaciejewskiDRTekieliŁMachnikR, et al.Simultaneous vertebral and subclavian artery stenting. Postepy w Kardiologii Interwencyjnej2017; 13: 142–149.
24.
MaNZhangYShuaiJ, et al.Stenting for symptomatic intracranial arterial stenosis in China: 1-year outcome of a multicentre registry study. Stroke and Vascular Neurology2018; 3: 176–184.
25.
BlaselSYükzekZKurreW, et al.Recanalization results after intracranial stenting of atherosclerotic stenoses. Cardiovasc Intervent Radiol2010; 33: 914–920.
26.
ZhuSGZhangRLLiuWH, et al.Predictive factors for in-stent restenosis after balloon-mounted stent placement for symptomatic intracranial atherosclerosis. Eur J Vasc Endovasc Surg2010; 40: 499–506.
27.
GengXHussainMDuH, et al.Comparison of self-expanding stents with distal embolic protection to balloon-expandable stents without a protection device in the treatment of symptomatic vertebral artery origin stenosis: a prospective randomized trial. J Endovasc Ther2015; 22: 436–444.
28.
LüPHParkJWParkS, et al.Intracranial stenting of subacute symptomatic atherosclerotic occlusion versus stenosis. Stroke2011; 42: 3470–3476.
29.
FreitasJMZentenoMAburto-MurrietaY, et al.Intracranial arterial stenting for symptomatic stenoses: a latin American experience. Surg Neurol2007; 68: 378–386.
30.
TangLHuPLiuY, et al.The experiences of balloon-expandable stent in symptomatic stenosis of middle cerebral artery. SpringerPlus2016; 5.
31.
ZaidatOOFitzsimmonsBFWoodwardBK, et al.Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA - Journal of the American Medical Association2015; 313: 1240–1248.
32.
BaikSHKwakHSChungGH,et al.Balloon-expandable stents for treatment of symptomatic middle cerebral artery stenosis: clinical outcomes during long-term follow-up. Interv Neuroradiol2018; 24: 666–673.
33.
KangKZhangYShuaiJ, et al.Balloon-mounted stenting for ICAS in a multicenter registry study in China: a comparison with the WEAVE/WOVEN trial. J Neurointerv Surg2020; 13: 894–899.
34.
JiangWJXuXTDuB, et al.Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology2007; 68: 420–426.
35.
von SchoenfeldtPKrützelmannABußmeyerM, et al.Elective treatment of intracranial stenosis with the balloon-expandable Pharos Vitesse stent: 30-day stroke rate and complications. J Neurointerv Surg2015; 7: 188–193.
36.
ShinYSKimBMSuhSH, et al.Wingspan stenting for intracranial atherosclerotic stenosis: clinical outcomes and risk factors for in-stent restenosis. Neurosurgery2013; 72: 596–604.
37.
GröschelKSchnaudigelSPilgramSM,et al.A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke2009; 40: e340–e347.
38.
WangDMChenHBLiuJC,et al.Treatment of patients older than 60 years with symptomatic vertebrobasilar artery stenosis. Chin Med J2008; 121: 1068–1071.
39.
KurreWBerkefeldJSitzerM,et al.Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable Pharos stent: initial experience. Neuroradiology2008; 50: 701–708.
40.
LiGWangNLiX, et al.Balloon-mounted versus self-expanding stent outcomes in symptomatic middle cerebral artery stenosis combined with poor collaterals in China: a multicenter registry study. World Neurosurg2019; 124: e675–ee81.
41.
ShenSWangYHeX, et al.Thirty-Day and one-year outcomes of endovascular treatments for severe atherosclerotic stenosis of intracranial ICA: results from a single center. Front Neurol2021; 12.
42.
TianCLiuBLiuJ, et al.Comparison of self-expandable stents and balloon-mounted stents in the treatment of symptomatic intracranial vertebral artery atherosclerotic stenosis. Am J Transl Res2021; 13: 1607–1616.
43.
AlexanderMJZaunerAGuptaR, et al.The WOVEN trial: wingspan one-year vascular events and neurologic outcomes. J Neurointerv Surg2021; 13: 307–310.
44.
TangLWangLLiC, et al.Treatment of basilar artery stenosis with an Apollo balloon-expandable stent: a single-centre experience with 61 consecutive cases. Acta Neurol Belg2020; 121: 1423–1427.
45.
MiaoZZhangYShuaiJ, et al.Thirty-day outcome of a multicenter registry study of stenting for symptomatic intracranial artery stenosis in China. Stroke2015; 46: 2822–2829.
46.
HenkesHMiloslavskiELowensS,et al.Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology2005; 47: 222–228.
47.
KesslerIMMounayerCPiotinM,et al.The use of balloon-expandable stents in the management of intracranial arterial diseases: a 5-year single-center experience. American Journal of Neuroradiology2005; 26: 2342–2348.
